| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910804 | Lung Cancer | 2015 | 8 Pages |
Abstract
These observations suggest that combined targeting of the ROCK and EGFR/HER pathways may be a potential therapeutic approach in limiting invasive growth in NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ijeoma Adaku Umelo, Olivier De Wever, Peter Kronenberger, Alfiah Noor, Erik Teugels, Gang Chen, Marc Bracke, Jacques De Grève,